Structure–activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor

Archives of Toxicology

Volumn 89, Issue 2, 2015, Pages 233-242

  Ren, Xiao Min ^a   Zhang, Yin Feng ^a   Guo, Liang Hong ^a   Qin, Zhan Fen ^a   Lv, Qi Yan ^a   Zhang, Lian Ying ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

Author keywords

Agonistic activity; Gene expression; Molecular docking; Perfluoroalkyl compounds; Thyroid hormone receptor

Indexed keywords

FLUOROCARBON; THYROID HORMONE RECEPTOR;

BINDING COMPETITION; CHEMISTRY; FLUORESCENCE; HUMAN; METABOLISM; MOLECULAR DOCKING; STRUCTURE ACTIVITY RELATION;

BINDING, COMPETITIVE; FLUORESCENCE; FLUOROCARBONS; HUMANS; MOLECULAR DOCKING SIMULATION; RECEPTORS, THYROID HORMONE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84930644658     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1258-y     Document Type: Article

References (45)

1. Benninghoff AD, Bisson WH, Koch DC, Ehresman DJ, Kolluri SK, William DE (2011) Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. Toxicol Sci 120(1):42–58
2. Bjork JA, Butenhoff JL, Wallace KB (2011) Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology 288(1):8–17
3. Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM (2006) Environmental chemicals and thyroid function. Eur J Endocrinol 154(5):599–611
4. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL (2007) Polyfluoroalkyl chemicals in the U.S. population: data from the national health and nutrition examination survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ Health Perspect 115(11):1596–1602
5. Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL (2008) Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctane sulfonate (PFOS). Toxicology 243(3):330–339
6. Chen YM, Guo LH (2009) Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin. Arch Toxicol 83(3):255–261
7. Cheng Y, Cui Y, Chen HM, Xie WP (2011) Thyroid disruption effects of environmental level perfluorooctane sulfonates (PFOS) in Xenopus laevis. Ecotoxicology 20(8):2069–2078
8. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RCJ, Scanlan TS (1998) A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 5(6):299–306
9. Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P (2009) Thyroid function and plasma concentrations of polyhalogenated compounds in inuit adults. Environ Health Perspect 117(9):1380–1386
10. Domingo JL, Ericson-Jogsten I, Perello G, Nadal M, Van Bavel B, Karrman A (2012) Human exposure to perfluorinated compounds in catalonia, spain: contribution of drinking water and fish and shellfish. J Agric Food Chem 60(17):4408–4415
11. Du G, Hu J, Huang H, Qin Y, Han X, Wu D, Song L, Xia Y, Wang X (2013) Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo. Environ Toxicol Chem 32(2):353–360
12. Fromme H, Tittlemier SA, Voelkel W, Wilhelm M, Twardella D (2009) Perfluorinated compounds-exposure assessment for the general population in western countries. Int J Hyg Environ Health 212(3):239–270
13. Gao Y, Li X, Guo LH (2013) Assessment of estrogenic activity of perfluoroalkyl acids based on ligand-induced conformation state of human estrogen receptor. Environ Sci Technol 47(1):634–641
14. Gutleb AC, Meerts IA, Bergsma JH, Schriks M, Murk AJ (2005) T-Screen as a tool to identify thyroid hormone receptor active compounds. Environ Toxicol Pharmacol 19(2):231–238
15. Gutshall DM, Pilcher GD, Langley AE (1989) Mechanism of the serum thyroid-hormone lowering effect of perfluoronormaldecanoic acid (PFDA) in rats. J Toxicol Environ Health 28(1):53–65
16. Harvey CB, Willians GR (2002) Mechanism of thyroid hormone action. Thyroid 12:441–448
17. Inoue A, Yamamoto N, Morisawa Y, Uchimoto T, Yukioka M, Morisawa S (1989) Unesterified long-chain fatty-acids inhibit thyroid-hormone binding to the nuclear receptor-solubilized receptor and the receptor in cultured-cells. Eur J Biochem 183(3):565–572
18. Kitamura S, Jinno N, Ohta S, Kuroki H, Fujimoto N (2002) Thyroid hormonal activity of the flame retardants tetrabromobisphenol a and tetrachlorobisphenol a. Biochem Biophys Res Commun 293(1):554–559
19. Lau C (2012) Perfluorinated compounds. EXS 101:47–86
20. Lau C, Butenhoff JL, Rogers JM (2004) The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231–241
21. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99(2):366–394
22. Li QL, Yamamoto N, Morisawa S, Inoue A (1993) Fatty acyl-CoA binding-activity of the nuclear thyroid-hormone receptor. J Cell Biochem 51(4):458–464
23. Liu Y, Wang J, Fang X, Zhang H, Dai J (2011) The thyroid-disrupting effects of long-term perfluorononanoate exposure on zebrafish (Danio rerio). Ecotoxicology 20(1):47–55
24. Long MH, Ghisari M, Bonefeld-Jorgensen EC (2013) Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res Int 20(11):8045–8056
25. Lopez-Espinosa MJ, Mondal D, Armstrong B, Bloom MS, Fletcher T (2012) Thyroid function and perfluoroalkyl acids in children living near a chemical plant. Environ Health Perspect 120(7):1036–1041
26. Lou QQ, Zhang YF, Zhou Z, Shi YL, Ge YN, Ren DK, Xu HM, Zhao YX, Wei WJ, Qin ZF (2013) Effects of perfluorooctanesulfonate and perfluorobutanesulfonate on the growth and sexual development of Xenopus laevis. Ecotoxicology 22(7):1133–1144
27. Luebker DJ, Hansen KJ, Bass NM, Butenhoff JL, Seacat AM (2002) Interactions of flurochemicals with rat liver fatty acid-binding protein. Toxicology 176(3):175–185
28. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS (2010) Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. national health and nutrition examination survey. Environ Health Perspect 118(5):686–692
29. Nieuwkoop PD, Faber J (1994) Normal table of Xenopus laevis (Daudin). Garland, New York
30. Norman MF, Lavin TN (1989) Antagonism of thyroid-hormone action by amiodarone in rat pituitary-tumor cells. J Clin Invest 83(1):306–313
31. Olsen GW, Burris JM, Burlew MM, Mandel JH (2003) Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45(3):260–270
32. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR (2007) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115(9):1298–1305
33. Ren XM, Guo LH, Gao Y, Zhang BT, Wan B (2013) Hydroxylated polybrominated diphenyl ethers exhibit different activities on thyroid hormone receptors depending on their degree of bromination. Toxicol Appl Pharmacol 268(3):256–263
34. Smith DS (1977) Enhancement fluoro-immunoassay of thyroxine. FEBS Lett 77(1):25–27
35. Stahl TMD, Brunn H (2011) Toxicology of perfluorinated compounds. Environ Sci Eur 23:38–89
36. Steenland K, Fletcher T, Savitz DA (2010) Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118(8):1100–1108
37. Takacs ML, Abbott BD (2007) Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci 95(1):108–117
38. Vongphachan V, Cassone CG, Wu D, Chiu S, Crump D, Kennedy SW (2011) Effects of perfluoroalkyl compounds on mRNA expression levels of thyroid hormone-responsive genes in primary cultures of avian neuronal cells. Toxicol Sci 120(2):392–402
39. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ (1995) A structural role for hormone in the thyroid hormone receptor. Nature 378:690–697
40. Weiss JM, Andersson PL, Lamoree MH, Leonards PEG, van Leeuwen SPJ, Hamers T (2009) Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol Sci 109(2):206–216
41. Wolf CJ, Takacs ML, Schmid JE, Lau C, Abbott BD (2008) Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths. Toxicol Sci 106(1):162–171
42. Wolf CJSJ, Lau C, Abbott BD (2012) Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFCAs): further investigation of C4–C12 compounds. Reprod Toxicol 33(4):546–551
43. Yu WG, Liu W, Jin YH (2009a) Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem 28(5):990–996
44. Yu WG, Liu W, Jin YH, Liu XH, Wang FQ, Liu L, Nakayama SF (2009b) Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system. Environ Sci Technol 43(21):8416–8422
45. Zhang L, Ren XM, Guo LH (2013) Structure-based investigation on the interaction of perfluorinated compounds with human liver fatty acid binding protein. Environ Sci Technol 47(19):11293–11301